Cargando…
Intravenous administration of piceatannol, an arginase inhibitor, improves endothelial dysfunction in aged mice
Advanced age is one of the risk factors for vascular diseases that are mainly caused by impaired nitric oxide (NO) production. It has been demonstrated that endothelial arginase constrains the activity of endothelial nitric oxide synthase (eNOS) and limits NO generation. Hence, arginase inhibition i...
Autores principales: | Nguyen, Minh Cong, Ryoo, Sungwoo |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
The Korean Physiological Society and The Korean Society of Pharmacology
2017
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5214914/ https://www.ncbi.nlm.nih.gov/pubmed/28066144 http://dx.doi.org/10.4196/kjpp.2017.21.1.83 |
Ejemplares similares
-
Increased arginase II activity contributes to endothelial dysfunction through endothelial nitric oxide synthase uncoupling in aged mice
por: Shin, Woosung, et al.
Publicado: (2012) -
Endothelial arginase II and atherosclerosis
por: Ryoo, Sungwoo, et al.
Publicado: (2011) -
Arginase Inhibition Restores Peroxynitrite-Induced Endothelial Dysfunction via L-Arginine-Dependent Endothelial Nitric Oxide Synthase Phosphorylation
por: Nguyen, Minh Cong, et al.
Publicado: (2016) -
Korean Red Ginseng Water Extract Restores Impaired Endothelial Function by Inhibiting Arginase Activity in Aged Mice
por: Choi, Kwanhoon, et al.
Publicado: (2014) -
Arginase Inhibitor in the Pharmacological Correction of Endothelial Dysfunction
por: Pokrovskiy, Mihail V., et al.
Publicado: (2011)